Cargando…
Parkinson’s disease model in zebrafish using intraperitoneal MPTP injection
INTRODUCTION: Parkinson’s disease (PD) is the second most common neurodegenerative disease that severely affects the quality of life of patients and their family members. Exposure to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) has been shown to reflect behavioral, molecular, and proteomic fe...
Autores principales: | Omar, Noor Azzizah, Kumar, Jaya, Teoh, Seong Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485380/ https://www.ncbi.nlm.nih.gov/pubmed/37694115 http://dx.doi.org/10.3389/fnins.2023.1236049 |
Ejemplares similares
-
Social behavioral changes in MPTP-treated monkey model of Parkinson's disease
por: Durand, Elodie, et al.
Publicado: (2015) -
Catalpol Exerts a Neuroprotective Effect in the MPTP Mouse Model of Parkinson’s Disease
por: Wang, Li-Yuan, et al.
Publicado: (2019) -
A novel biomechanical analysis of gait changes in the MPTP mouse model of Parkinson’s disease
por: Geldenhuys, Werner J., et al.
Publicado: (2015) -
Smilagenin Protects Dopaminergic Neurons in Chronic MPTP/Probenecid—Lesioned Parkinson’s Disease Models
por: He, Xuan, et al.
Publicado: (2019) -
Intraperitoneal Injection into Adult Zebrafish
por: Kinkel, Mary D., et al.
Publicado: (2010)